Abstract
Background:
The adaptive immune system of neonates is relatively underdeveloped. The thymus is an essential organ for adaptive T cell development and might be affected during the natural course of oxygen induced lung injury. The effect of prolonged hyperoxia on the thymus, thymocyte and T cell development, and its proliferation has not been studied extensively.
Methods:
Neonatal mice were exposed to 85% oxygen (hyperoxia) or room air (normoxia) up to 28 days. Flow cytometry using surface markers were used to assay for thymocyte development and proliferation.
Results:
Mice exposed to prolonged hyperoxia had evidence of lung injury associated alveolar simplification, a significantly lower mean weight, smaller thymic size, lower mean thymocyte count and higher percentage of apoptotic thymocytes. T cells subpopulation in the thymus showed a significant reduction in the count and proliferation of double positive and double negative T cells. There was a significant reduction in the count and proliferation of single positive CD4+ and CD8+ T cells.
Conclusions:
Prolonged hyperoxia in neonatal mice adversely affected thymic size, thymocyte count and altered the distribution of T cells sub-populations. These results are consistent with the hypothesis that prolonged hyperoxia causes defective development of T cells in the thymus.
Authors’ contributions
SA, TM, SO, BS and JL conceived, prepared the study design, protocol and obtained approval from Institutional animal care and Use committee. S A, TM, RH performed the animal experiments. SA, TM, SO, BS, RH, JH, MA and JL analyzed the data, wrote, reviewed and edited the manuscript. MA and JH prepared the histopathology, reviewed and edited the manuscript. The manuscript was prepared, reviewed and approved by all authors prior to submission.
Author’s statement
Conflict of interest: Authors state no conflict of interest.
Material and methods: Informed consent: Informed consent has been obtained from all individuals included in this study.
Ethical approval: The research related to human subject use has complied with all the relevant national regulations, and institutional policies, and is in accordance with the tenets of the Helsinki Declaration, and has been approved by the authors’ institutional review board or equivalent committee.
References
[1] Bhandari V, Elias JA. Cytokines in tolerance to hyperoxia-induced injury in the developing and adult lung. Free Radic Biol Med. 2006;41:4–18.10.1016/j.freeradbiomed.2006.01.027Search in Google Scholar
[2] Waxman AB, Einarsson O, Seres T, Knickelbein RG, Warshaw JB, Johnston R, et al. Targeted lung expression of interleukin-11 enhances murine tolerance of 100% oxygen and diminishes hyperoxia-induced DNA fragmentation. J Clin Invest. 1998;101:1970–82.10.1172/JCI1337Search in Google Scholar
[3] Warner BB, Stuart LA, Papes RA, Wispe JR. Functional and pathological effects of prolonged hyperoxia in neonatal mice. Am J Physiol. 1998;275:L110–17.10.1152/ajplung.1998.275.1.L110Search in Google Scholar
[4] Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2001;63:1723–9.10.1164/ajrccm.163.7.2011060Search in Google Scholar
[5] Rosen D, Lee J, Cuttitta F, Rafiqi F, Degan S, Mary E. Accelearted thymic maturation and autorecative T cells in bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2006;174:75–83.10.1164/rccm.200511-1784OCSearch in Google Scholar
[6] Boehm T. Thymus development and function. Curr Opin Immunol. 2008;20:178–84.10.1016/j.coi.2008.03.001Search in Google Scholar
[7] Hogquist KA. Signal strength in thymic selection and lineage commitment. Curr Opin Immunol. 2001;13:225–31.10.1016/S0952-7915(00)00208-9Search in Google Scholar
[8] Von Boehmer H, Melchers F. Checkpoints in lymphocyte development and autoimmune disease. Nat Immunol. 2010;11:14–20.10.1038/ni.1794Search in Google Scholar PubMed
[9] Bonikos DS, Bensch KG, Northway WH. Oxygen toxicity in the newborn. The effect of chronic continuous 100% oxygen oxygen exposure on the lungs of the newborn mice. Am J Pathol. 1976;85:623–50.Search in Google Scholar
[10] Johnston CJ, Wright TW, Reed CK, Finkelstein JN. Comparison of adult and newborn pulmonary cytokine mRNA expression after hyperoxia. Exp Lung Res. 1997;23:537–52.10.3109/01902149709039242Search in Google Scholar PubMed
[11] Ambalavanan N, Carlo WA, D’Angio CT, McDonald SA, Das A, Schendel D, et al. Cytokines associated with bronchopulmonary dysplasia or death in extremely low birth weight infants. Pediatrics. 2009;123:1132–40.10.1542/peds.2008-0526Search in Google Scholar PubMed PubMed Central
[12] Ambalavanan N, Van Meurs KP, Perritt R, Carlo WA, Ehrenkranz RA, Stevenson DK, et al. NICHD Neonatal Research Network, Bethesda, MD. Predictors of death or bronchopulmonary dysplasia in preterm infant with respiratory failure. J Perinatol. 2008;28:420–6.10.1038/jp.2008.18Search in Google Scholar
[13] Barazzone-Argiroffo C, Muzzin P, Donati Y, Kan C, Aubert M, Piguet P. Hyperoxia increases leptin production: a mechanism mediated through endogenous elevation of corticosterone. Am J Physiol Lung Cell Mol Physiol. 2001;281:L1150–6.10.1152/ajplung.2001.281.5.L1150Search in Google Scholar
[14] Berry MA, Abrahamowicz M, Usher R. Factors associated with growth of extremely premature infants during initial hospitalization. Pediatrics. 1997;100:640–6.10.1542/peds.100.4.640Search in Google Scholar
[15] Henry K. The Thymus gland. In: Symmers WC, editors. Systemic pathology. 3rd ed. London: Churchill Livingstone; 1992; V7. p. 27–139.Search in Google Scholar
[16] Barazzone-Argiroffo C, Pagano A, Juge C, Métrailler I, Rochat A, Vesin C, et al. Glucocorticoids aggravate hyperoxia-induced lung injury through decreased nuclear factor-B activity. Am J Physiol Lung Cell Mol Physiol. 2003;284:L197–204.10.1152/ajplung.00239.2002Search in Google Scholar
[17] Fletcher BD, Masson MM, Lisbona A, Riggs T, Papageorgiou AN. Thymic response to endogenous and exogenous steroids in premature newborn infants. J Pediatr. 1979;95:111–4.10.1016/S0022-3476(79)80100-6Search in Google Scholar
[18] Ma DD, Ho AH, Hoffbrand AV. Effect of thymosin on glucocorticoid receptor receptor activity and glucocorticoid sensitivity of human thymocytes. Clin Exp Immunol. 1984;55:273–80.Search in Google Scholar
[19] Wyllie AH. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature. 1980;284:555–6.10.1038/284555a0Search in Google Scholar
[20] van Baarlen J, Schuurman HJ, Reitsma R, Huber J. Acute thymus involution during infancy and childhood: immunohistology of the thymus and peripheral lymphoid tissues after acute illness. Pediatr Pathol. 1989;9:261–75.10.3109/15513818909037731Search in Google Scholar
[21] van Baarlen J, Schuurman HJ, Huber J. Acute thymus involution in infancy and childhood: a reliable marker for duration of acute illness. Hum Pathol. 1988;19:1155–60.10.1016/S0046-8177(88)80146-1Search in Google Scholar
[22] De Felice C, Latini G, Del Vecchio A, Toti P, Bagnoli F, Petraglia F. Small thymus at birth: a predictive radiographic sign of bronchopulmonary dysplasia. Pediatrics. 2002;110:386–8.10.1542/peds.110.2.386Search in Google Scholar PubMed
[23] Kunzmann S, Glogger K, Been JV, Kallapur S, Nitsos I, Moss T, et al. Thymic changes after chorioamnionitis induced by intraamniotic lipopolysaccharide in fetal sheep. Am J Obstet Gynecol. 2010;202:476.10.1016/j.ajog.2010.02.035Search in Google Scholar PubMed PubMed Central
[24] Svec P, Vasarhelyi B, Cizmar A, Tulassay T, Treszl A. Resistance of human regulatory Foxp3+ T cells to normobaric hyperoxia exposure under resting and stimulating conditions. Scand J Immunol. 2011;73:215–21.10.1111/j.1365-3083.2010.02492.xSearch in Google Scholar PubMed
[25] Diepenbruck I, Much CC, Krumbholz A, Kolster M, Thieme R, Thieme D, et al. Effect of prenatal steroid treatment on the developing immune system. J Mol Med. 2013;91:1293–302.10.1007/s00109-013-1069-2Search in Google Scholar PubMed
Supplemental Material:
The online version of this article (DOI: https://doi.org/10.1515/jpm-2016-0234) offers supplementary material, available to authorized users.
©2018 Walter de Gruyter GmbH, Berlin/Boston
